Published in PLoS One on September 05, 2008
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 10.56
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol (2011) 8.21
Detection of microRNA expression in human peripheral blood microvesicles. PLoS One (2008) 8.04
The microRNA spectrum in 12 body fluids. Clin Chem (2010) 6.82
Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods (2010) 6.25
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA. Cell Res (2011) 4.55
Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J (2010) 4.47
Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One (2010) 3.23
Serum microRNAs as non-invasive biomarkers for cancer. Mol Cancer (2010) 2.95
Detection of cancer with serum miRNAs on an oligonucleotide microarray. PLoS One (2009) 2.68
A pilot study of circulating miRNAs as potential biomarkers of early stage breast cancer. PLoS One (2010) 2.64
Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients. PLoS One (2009) 2.55
MicroRNAs and cardiac pathology. Nat Rev Cardiol (2009) 2.50
Human placental trophoblasts confer viral resistance to recipient cells. Proc Natl Acad Sci U S A (2013) 2.42
Impact of cellular miRNAs on circulating miRNA biomarker signatures. PLoS One (2011) 2.24
Plasma microRNAs as novel biomarkers for endometriosis and endometriosis-associated ovarian cancer. Clin Cancer Res (2013) 2.15
Immune-related microRNAs are abundant in breast milk exosomes. Int J Biol Sci (2011) 2.11
Circulating micro-RNA expression profiles in early stage nonsmall cell lung cancer. Int J Cancer (2011) 2.02
MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro Oncol (2012) 2.02
Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood (2012) 1.80
Up-regulation of circulating miR-20a is correlated with hepatitis C virus-mediated liver disease progression. Hepatology (2013) 1.79
Comprehensive profiling of circulating microRNA via small RNA sequencing of cDNA libraries reveals biomarker potential and limitations. Proc Natl Acad Sci U S A (2013) 1.79
Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One (2011) 1.78
Epigenetics in the placenta. Am J Reprod Immunol (2009) 1.77
Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci (2012) 1.76
MicroRNAs as Novel Biomarkers for Breast Cancer. J Oncol (2009) 1.72
Circulating microRNAs in patients with active pulmonary tuberculosis. J Clin Microbiol (2011) 1.70
Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol (2013) 1.69
Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One (2012) 1.66
miRNAs in lung cancer - studying complex fingerprints in patient's blood cells by microarray experiments. BMC Cancer (2009) 1.61
MicroRNAs as biomarkers in rheumatic diseases. Nat Rev Rheumatol (2010) 1.59
Whole blood-derived miRNA profiles as potential new tools for ovarian cancer screening. Br J Cancer (2010) 1.54
Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease. Exp Neurol (2011) 1.49
MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2. PLoS One (2015) 1.48
Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer (2013) 1.48
Profiling of circulating microRNAs: from single biomarkers to re-wired networks. Cardiovasc Res (2011) 1.47
Profiling of serum and urinary microRNAs in children with atopic dermatitis. PLoS One (2014) 1.46
MicroRNAs: critical mediators of differentiation, development and disease. Swiss Med Wkly (2009) 1.43
Extracellular/circulating microRNAs and their potential role in cardiovascular disease. Am J Cardiovasc Dis (2011) 1.43
Role of miRNAs in the progression of malignant melanoma. Br J Cancer (2009) 1.41
miRNAS in normal and diseased skeletal muscle. J Cell Mol Med (2009) 1.41
Expression profiling of cancerous and normal breast tissues identifies microRNAs that are differentially expressed in serum from patients with (metastatic) breast cancer and healthy volunteers. Breast Cancer Res (2012) 1.39
Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. Prostate (2012) 1.39
Circulating miR-17, miR-20a, miR-29c, and miR-223 combined as non-invasive biomarkers in nasopharyngeal carcinoma. PLoS One (2012) 1.37
Cell-free Circulating miRNA Biomarkers in Cancer. J Cancer (2012) 1.37
Diagnosis of pancreatic ductal adenocarcinoma and chronic pancreatitis by measurement of microRNA abundance in blood and tissue. PLoS One (2012) 1.36
Detection of differentially expressed microRNAs in serum of pancreatic ductal adenocarcinoma patients: miR-196a could be a potential marker for poor prognosis. Dig Dis Sci (2010) 1.35
A critical evaluation of microRNA biomarkers in non-neoplastic disease. PLoS One (2014) 1.35
Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med (2014) 1.34
High-throughput miRNA profiling of human melanoma blood samples. BMC Cancer (2010) 1.32
The levels of hypoxia-regulated microRNAs in plasma of pregnant women with fetal growth restriction. Placenta (2010) 1.32
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J Transl Med (2012) 1.31
MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. Arthritis Rheum (2011) 1.31
Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res (2011) 1.30
MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol (2011) 1.29
Serum-based microRNAs: are we blinded by potential? Proc Natl Acad Sci U S A (2008) 1.28
Discovery of microRNAs and other small RNAs in solid tumors. Nucleic Acids Res (2010) 1.28
Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS One (2013) 1.27
Lactation-related microRNA expression profiles of porcine breast milk exosomes. PLoS One (2012) 1.24
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res (2010) 1.22
Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance. Haematologica (2013) 1.22
miRNAs as modulators of angiogenesis. Cold Spring Harb Perspect Med (2013) 1.21
Plasma miRNAs as diagnostic and prognostic biomarkers for ovarian cancer. PLoS One (2013) 1.20
Genome-wide identification of Schistosoma japonicum microRNAs using a deep-sequencing approach. PLoS One (2009) 1.20
MicroRNA functions in osteogenesis and dysfunctions in osteoporosis. Curr Osteoporos Rep (2013) 1.19
Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn (2010) 1.19
A panel of 4 microRNAs facilitates the prediction of left ventricular contractility after acute myocardial infarction. PLoS One (2013) 1.19
Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One (2014) 1.18
miRNA Biomarkers in Breast Cancer Detection and Management. J Cancer (2011) 1.18
Transcriptome profiling of microRNA by Next-Gen deep sequencing reveals known and novel miRNA species in the lipid fraction of human breast milk. PLoS One (2013) 1.17
MicroRNAs are shaping the hematopoietic landscape. Haematologica (2011) 1.17
Next-generation sequencing of microRNAs for breast cancer detection. J Biomed Biotechnol (2011) 1.17
Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Ann Rheum Dis (2013) 1.16
Clinical impact of down-regulated plasma miR-92a levels in non-Hodgkin's lymphoma. PLoS One (2011) 1.15
Biomarkers for smoking cessation. Clin Pharmacol Ther (2013) 1.15
Peripheral blood miR-328 expression as a potential biomarker for the early diagnosis of NSCLC. Int J Mol Sci (2013) 1.15
Circulating microRNAs as biomarkers, therapeutic targets, and signaling molecules. Sensors (Basel) (2012) 1.15
Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction. Clinics (Sao Paulo) (2013) 1.14
MicroRNA modulation in complex regional pain syndrome. J Transl Med (2011) 1.14
Exosomal and Non-Exosomal Transport of Extra-Cellular microRNAs in Follicular Fluid: Implications for Bovine Oocyte Developmental Competence. PLoS One (2013) 1.13
Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. J Transl Med (2013) 1.12
Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort. Breast Cancer Res (2013) 1.12
Altered microRNA signatures in sputum of patients with active pulmonary tuberculosis. PLoS One (2012) 1.12
Temporal- and strain-specific host microRNA molecular signatures associated with swine-origin H1N1 and avian-origin H7N7 influenza A virus infection. J Virol (2012) 1.12
Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia. J Transl Med (2013) 1.11
Exosomes: novel biomarkers for clinical diagnosis. ScientificWorldJournal (2015) 1.11
Salivary microRNAs as promising biomarkers for detection of esophageal cancer. PLoS One (2013) 1.10
MicroRNAs in insulin resistance and obesity. Exp Diabetes Res (2012) 1.10
A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn (2010) 1.09
Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis. PLoS One (2013) 1.09
Challenges in using circulating miRNAs as cancer biomarkers. Biomed Res Int (2015) 1.08
The role of microRNAs in ovarian cancer initiation and progression. J Cell Mol Med (2010) 1.08
Influence of plasma processing on recovery and analysis of circulating nucleic acids. PLoS One (2013) 1.08
Serum microRNA expression profile distinguishes enterovirus 71 and coxsackievirus 16 infections in patients with hand-foot-and-mouth disease. PLoS One (2011) 1.08
The detection of microRNA associated with Alzheimer's disease in biological fluids using next-generation sequencing technologies. Front Genet (2013) 1.08
MicroRNAs as lung cancer biomarkers. World J Clin Oncol (2014) 1.07
MicroRNAs--novel regulators of systemic lupus erythematosus pathogenesis. Nat Rev Rheumatol (2012) 1.06
MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy. Carcinogenesis (2012) 1.06
Whole blood-derived microRNA signatures in mice exposed to lipopolysaccharides. J Biomed Sci (2012) 1.06
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
MicroRNA expression profiles classify human cancers. Nature (2005) 69.12
MicroRNA signatures in human cancers. Nat Rev Cancer (2006) 46.29
A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09
Identification of tissue-specific microRNAs from mouse. Curr Biol (2002) 34.55
Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet (2005) 15.96
microRNA functions. Annu Rev Cell Dev Biol (2007) 15.74
The colorectal microRNAome. Proc Natl Acad Sci U S A (2006) 11.59
Characterization of microRNA expression profiles in normal human tissues. BMC Genomics (2007) 8.01
MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol (2008) 7.27
Detection and characterization of placental microRNAs in maternal plasma. Clin Chem (2008) 6.40
Facile means for quantifying microRNA expression by real-time PCR. Biotechniques (2005) 5.04
Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol (2007) 4.40
Pre-eclampsia. Lancet (2000) 3.58
Raising the estimate of functional human sequences. Genome Res (2007) 3.43
Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat Med (2007) 3.34
Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol (2007) 2.78
MicroRNAs in disease and potential therapeutic applications. Mol Ther (2007) 2.73
Circulating (cell-free) nucleic acids--a promising, non-invasive tool for early detection of several human diseases. FEBS Lett (2007) 2.43
Camels and zebrafish, viruses and cancer: a microRNA update. Hum Mol Genet (2005) 2.18
Evolution of the mammalian placenta revealed by phylogenetic analysis. Proc Natl Acad Sci U S A (2006) 1.89
Pregnancy-related mortality surveillance--United States, 1987-1990. MMWR CDC Surveill Summ (1997) 1.30
Circulating RNA as a tumor marker: detection of 5T4 mRNA in breast and lung cancer patient serum. Ann N Y Acad Sci (2001) 1.29
Circulating nucleic acids in plasma and serum: recent developments. Ann N Y Acad Sci (2006) 1.14
Hyperglycemia and adverse pregnancy outcomes. N Engl J Med (2008) 25.36
International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care (2010) 18.00
Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet (2005) 15.96
The colorectal microRNAome. Proc Natl Acad Sci U S A (2006) 11.59
Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell (2007) 9.51
MicroRNAs accurately identify cancer tissue origin. Nat Biotechnol (2008) 7.27
MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res (2004) 6.98
Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care (2007) 6.38
Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. Bioinformatics (2004) 4.88
Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol (2005) 3.87
Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol (2009) 3.47
Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis. Mol Cell Biol (2002) 3.30
The hyperglycemia and adverse pregnancy outcome study: associations of GDM and obesity with pregnancy outcomes. Diabetes Care (2012) 2.61
miR-24-mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat Struct Mol Biol (2009) 2.54
Identification of a novel stress-responsive gene Hi95 involved in regulation of cell viability. Oncogene (2002) 2.52
Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care (2012) 2.29
Serum levels of microRNAs in patients with heart failure. Eur J Heart Fail (2011) 2.08
Assessment of iodine intake in the Israel coastal area. Isr Med Assoc J (2004) 1.97
Role of fetal length in the prediction of fetal weight. J Ultrasound Med (2012) 1.97
Chronic immune activation associated with chronic helminthic and human immunodeficiency virus infections: role of hyporesponsiveness and anergy. Clin Microbiol Rev (2004) 1.95
MiR-92b and miR-9/9* are specifically expressed in brain primary tumors and can be used to differentiate primary from metastatic brain tumors. Brain Pathol (2008) 1.90
Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2013) 1.83
Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res (2010) 1.81
Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk. Nat Immunol (2011) 1.67
Treatment of intestinal worms is associated with decreased HIV plasma viral load. J Acquir Immune Defic Syndr (2002) 1.59
MicroRNA expression patterns and function in endodermal differentiation of human embryonic stem cells. PLoS One (2008) 1.56
miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood (2009) 1.54
Maternal obesity: implications for pregnancy outcome and long-term risks-a link to maternal nutrition. Int J Gynaecol Obstet (2011) 1.46
Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients. Gynecol Oncol (2009) 1.44
Overweight and obese in gestational diabetes: the impact on pregnancy outcome. Am J Obstet Gynecol (2005) 1.41
Mode of delivery following successful external cephalic version. Am J Perinatol (2002) 1.41
Comparison of body mass index and body surface area as outcome predictors in patients with systolic heart failure. Cardiol J (2015) 1.41
Contribution of the addition of anti-β2-glycoprotein to the classification of antiphospholipid syndrome in predicting adverse pregnancy outcome. J Matern Fetal Neonatal Med (2010) 1.39
Pregnancy outcome after third trimester amniocentesis: a single center experience. J Matern Fetal Neonatal Med (2011) 1.38
Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults. J Infect Dis (2005) 1.37
Comprehensive gene and microRNA expression profiling reveals a role for microRNAs in human liver development. PLoS One (2009) 1.37
HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology (2009) 1.35
hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy. Cancer Res (2010) 1.35
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations of maternal A1C and glucose with pregnancy outcomes. Diabetes Care (2012) 1.34
Short-term neonatal outcome in low-risk, spontaneous, singleton, late preterm deliveries. Obstet Gynecol (2009) 1.33
Pro-tumorigenic effects of miR-31 loss in mesothelioma. J Biol Chem (2010) 1.31
MicroRNAs as a potential prognostic factor in gastric cancer. World J Gastroenterol (2011) 1.29
Discovery of microRNAs and other small RNAs in solid tumors. Nucleic Acids Res (2010) 1.28
Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. Am J Obstet Gynecol (2004) 1.28
hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma. Cancer Res (2010) 1.22
Prospective gene signature study using microRNA to identify the tissue of origin in patients with carcinoma of unknown primary. Clin Cancer Res (2011) 1.21
Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study. Diabetes Care (2009) 1.20
Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med (2011) 1.19
Accurate molecular classification of renal tumors using microRNA expression. J Mol Diagn (2010) 1.19
The diagnosis of gestational diabetes mellitus: new paradigms or status quo? J Matern Fetal Neonatal Med (2012) 1.18
Pregnancy outcome at extremely advanced maternal age. Am J Obstet Gynecol (2010) 1.18
Sonographic diagnosis of ovarian torsion: accuracy and predictive factors. J Ultrasound Med (2011) 1.18
CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention. AIDS (2002) 1.17
Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstet Gynecol (2003) 1.15
Validation of a microRNA-based qRT-PCR test for accurate identification of tumor tissue origin. Mod Pathol (2010) 1.15
Fetal gender and pregnancy outcome. J Matern Fetal Neonatal Med (2010) 1.12
Blocking of cell-free and cell-associated HIV-1 transmission through human cervix organ culture with UC781. AIDS (2003) 1.10
4sUDRB-seq: measuring genomewide transcriptional elongation rates and initiation frequencies within cells. Genome Biol (2014) 1.10
Intrapartum cervical lacerations: characteristics, risk factors, and effects on subsequent pregnancies. Am J Obstet Gynecol (2009) 1.10
The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med (2013) 1.10
Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care (2012) 1.10
A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn (2010) 1.09
Gestational diabetes screening: the low-cost algorithm. Int J Gynaecol Obstet (2011) 1.08
Pregnancy outcome in patients with pulmonary arterial hypertension receiving prostacyclin therapy. Obstet Gynecol (2005) 1.04
Gene silencing of mannose 6-phosphate reductase in the parasitic weed Orobanche aegyptiaca through the production of homologous dsRNA sequences in the host plant. Plant Biotechnol J (2009) 1.02
Indicated labor induction with vaginal prostaglandin E2 increases the risk of cesarean section even in multiparous women with no previous cesarean section. J Perinat Med (2004) 1.01